S1393
An Act relative to preventing overdose deaths and increasing access to treatment
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Bill overview
This bill aims to reduce overdose deaths and improve access to treatment for substance use disorders in Massachusetts. It seeks to expand access to naloxone, a medication that can reverse opioid overdoses, and increase the availability of medication-assisted treatment programs. The legislation also intends to support harm reduction services and promote comprehensive recovery support.
Key provisions
- Expand access to naloxone for individuals and communities.
- Increase funding for medication-assisted treatment programs.
- Support harm reduction services, such as syringe exchange programs.
- Promote comprehensive recovery support services.
- Require health insurance coverage for evidence-based substance use disorder treatment.
Who is affected
- Individuals struggling with substance use disorders
- Families affected by substance use disorders
- Healthcare providers
- Public health officials
- Insurance companies
Notable changes
- The bill focuses on expanding access to existing resources rather than creating entirely new programs.
- It emphasizes a harm reduction approach alongside treatment options.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Adam J. Scanlon
Brendan P. Crighton
Dylan A. Fernandes
James B. Eldridge
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill S.1393 194th (Current)
An Act relative to preventing overdose deaths and increasing access to treatment
By Mr. Cyr, a petition (accompanied by bill, Senate, No. 1393) of Julian Cyr, Joanne M. Comerford, Jason M. Lewis, John F. Keenan and other members of the Senate for legislation relative to preventing overdose deaths and increasing access to treatment. Mental Health, Substance Use and Recovery.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: Julian Cyr Status: Referred to Senate Committee on Ways and Means
Tabs
Bill History Petitioners Committee Vote Fiscal Note Primary Sponsor Summary
Bill History
Displaying 5 actions for Bill S.1393
| Date | Branch | Action |
| 2/27/2025 | Senate | Referred to the committee on Mental Health, Substance Use and Recovery |
| 2/27/2025 | House | House concurred |
| 8/7/2025 | Joint | Hearing scheduled for 09/15/2025 from 11:00 AM-05:00 PM in Gardner Auditorium |
| 1/12/2026 | Senate | Bill reported favorably by committee and referred to the committee on Health Care Financing |
| 3/12/2026 | Senate | Committee recommended ought to pass and referred to the committee on Senate Ways and Means |
Similar Bills
S.1272 192nd (2021 - 2022)
An Act relative to preventing overdose deaths and increasing access to treatment
S.1242 193rd (2023 - 2024)
An Act relative to preventing overdose deaths and increasing access to treatment
S.2717 191st (2019 - 2020)
An Act relative to preventing overdose deaths and increasing access to treatment
S.1134 191st (2019 - 2020)
An Act relative to supervised injection facilities
S.1258 192nd (2021 - 2022)
An Act relative to supervised consumption sites
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.